CARMIL2 and inflammatory bowel disease: Patient 3 and Patient 4 were identified by screening for biallelic CARMIL2 variants from WES data in a cohort of 1005 pediatric IBD patients enrolled at SickKids, Toronto, as described in the “Methods”29.